Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Multiple Sclerosis

Free Subscription 29.04.2024 1 BMC Neurol 1 J Neuroimmunol 2 J Neurol 3 Mult Scler 4 Neurology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. SELLITTO G, Ruotolo I, Ianniello A, Felicetti F, et al
   Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.
   BMC Neurol. 2024;24:138.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

2. LI V, Binder MD, Purcell AW, Kilpatrick TJ, et al
   Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis.
   J Neuroimmunol. 2024;390:578347.
   PubMed         Abstract available
   
   

   
   J Neurol

3. ROSENSTEIN I, Nordin A, Sabir H, Malmestrom C, et al
   Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis.
   J Neurol. 2024 Apr 26. doi: 10.1007/s00415-024-12389.
   PubMed         Abstract available
   
   
4. NAUTA IM, van Dam M, Bertens D, Kessels RPC, et al
   Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial.
   J Neurol. 2024 Apr 23. doi: 10.1007/s00415-024-12327.
   PubMed         Abstract available
   
   

   
   Mult Scler

5. MANUEL AM, Gottlieb A, Freeman L, Zhao Z, et al
   Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data.
   Mult Scler. 2024 Apr 25:13524585241240398. doi: 10.1177/13524585241240398.
   PubMed         Abstract available
   
   
6. BIANCHI A, Cortese R, Prados F, Tur C, et al
   Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
   Mult Scler. 2024 Apr 22:13524585241240420. doi: 10.1177/13524585241240420.
   PubMed         Abstract available
   
   
7. NOVAK F, Bajwa HM, Ostergaard K, Berg JM, et al
   Extended interval dosing with ocrelizumab in multiple sclerosis.
   Mult Scler. 2024 Apr 22:13524585241245296. doi: 10.1177/13524585241245296.
   PubMed         Abstract available
   
   

   
   Neurology

8. MICHAELSON NM
   Right Brain: The Unraveling.
   Neurology. 2024;102:e209492.
   PubMed         Abstract available
   
   
9. VYAS MV, Kapral MK, Alonzo R, Fang J, et al
   Proportion of Life Spent in Canada and the Incidence of Multiple Sclerosis in Permanent Immigrants.
   Neurology. 2024;102:e209350.
   PubMed         Abstract available
   
   
10. SILBERMANN E, Spain RI
    Serum Neurofilament Light Chain for Multiple Sclerosis Relapses: Too Little Too Late?
    Neurology. 2024;102:e209456.
    PubMed        
    
    
11. FOX RJ, Cree BAC, de Seze J, Gold R, et al
    Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e209357.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.